-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, W0YRG4BHxDhrCVZyT05Dirrf0futWSney81DvU6gZDfVc6whfY80HqRnlKZUkH1h B2WIDX8fW4icBLrxXeaw+g== 0000820081-06-000067.txt : 20061116 0000820081-06-000067.hdr.sgml : 20061116 20061116145016 ACCESSION NUMBER: 0000820081-06-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061115 FILED AS OF DATE: 20061116 DATE AS OF CHANGE: 20061116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SARGEN GREGORY CENTRAL INDEX KEY: 0001227835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 061222764 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 20180430111 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-11-15 0000820081 CAMBREX CORP CBM 0001227835 SARGEN GREGORY ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073 0 1 0 0 Vice President-Finance Common Stock 2006-11-15 4 M 0 75000 18.675 A 76000 D Common Stock 2006-11-15 4 M 0 7000 20.72 A 83000 D Common Stock 2006-11-15 4 M 0 5000 21.9025 A 88000 D Common Stock 2006-11-15 4 S 0 500 22.50 D 87500 D Common Stock 2006-11-15 4 S 0 100 22.55 D 87400 D Common Stock 2006-11-15 4 S 0 900 22.56 D 86500 D Common Stock 2006-11-15 4 S 0 1600 22.57 D 84900 D Common Stock 2006-11-15 4 S 0 2600 22.58 D 82300 D Common Stock 2006-11-15 4 S 0 2100 22.59 D 80200 D Common Stock 2006-11-15 4 S 0 8600 22.60 D 71600 D Common Stock 2006-11-15 4 S 0 600 22.61 D 71000 D Common Stock 2006-11-15 4 S 0 15500 22.62 D 55500 D Common Stock 2006-11-15 4 S 0 700 22.63 D 54800 D Common Stock 2006-11-15 4 S 0 1600 22.64 D 53200 D Common Stock 2006-11-15 4 S 0 2000 22.65 D 51200 D Common Stock 2006-11-15 4 S 0 1700 22.66 D 49500 D Common Stock 2006-11-15 4 S 0 3100 22.67 D 46400 D Common Stock 2006-11-15 4 S 0 3900 22.68 D 42500 D Common Stock 2006-11-15 4 S 0 7100 22.69 D 35400 D Common Stock 2006-11-15 4 S 0 1100 22.70 D 34300 D Common Stock 2006-11-15 4 S 0 400 22.71 D 33900 D Common Stock 2006-11-15 4 S 0 3300 22.72 D 30600 D Common Stock 2006-11-15 4 S 0 1000 22.73 D 29600 D Common Stock 2006-11-15 4 S 0 500 22.74 D 29100 D Common Stock 2006-11-15 4 S 0 800 22.76 D 28300 D Common Stock 2006-11-15 4 S 0 800 22.77 D 27500 D Common Stock 2006-11-15 4 S 0 300 22.78 D 27200 D Common Stock 2006-11-15 4 S 0 200 22.79 D 27400 D Common Stock 2006-11-15 4 S 0 400 22.80 D 27000 D Common Stock 2006-11-15 4 S 0 400 22.92 D 26600 D Stock Option (Right to Buy) 18.675 2006-11-15 4 M 0 75000 0 D 2004-04-24 2010-04-24 Common Stock 75000 0 D Stock Option (Right to Buy) 20.72 2006-11-15 4 M 0 7000 0 D 2005-12-31 2012-07-25 Common Stock 7000 0 D Stock Option (Right to Buy) 21.9025 2004-08-23 4 M 0 5000 0 A 2004-12-31 2011-08-23 Common Stock 5000 5000 D Stock Option (Right to Buy) 21.9025 2006-11-15 4 M 0 5000 0 D 2004-12-31 2011-08-23 Common Stock 5000 0 D First one-quarter of said grant exercisable in whole or in part one year from the date of grant, with a further one quarter of each such grant becoming exercisable on each of the next three anniversaries of such grant date. Vesting of this grant was accelerated by the Compensation Committee of the Board of Directors on June 1, 2005. The sales restrictions on this grant to reporting person were lifted On November 2, 2006 by the Compensation Committee of the Board of Directors. Exercisable in one-quarter increments over four years from the date of grant. Vesting of this grant to reporting person was accelerated by the Compensation Committee of the Board of Directors on June 1, 2005. 200 shares at $22.79; 400 shares at $22.80; 400 shares at $22.92; 300 shares sold at $22.94; 10,000 shares sold at $22.95; 100 shares sold at $22.96; 12,600 shares sold at $22.97; 400 shares sold at $22.98; 800 shares sold at 22.99; 1,000 shares sold at $23.00. Amount of Securities benefically owned following reported transactions 1,000 shares directly held. Linda Kresse for Gregory P. Sargen by POA 2006-11-16 -----END PRIVACY-ENHANCED MESSAGE-----